BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19232749)

  • 1. Effect of anti-GM2 antibodies on rat sciatic nerve: electrophysiological and morphological study.
    Ortiz N; Sabaté MM; Garcia N; Santafe MM; Lanuza MA; Tomàs M; Tomàs J
    J Neuroimmunol; 2009 Mar; 208(1-2):61-9. PubMed ID: 19232749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
    Lopate G; Choksi R; Pestronk A
    Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein.
    Tatum AH
    Ann Neurol; 1993 May; 33(5):502-6. PubMed ID: 7684583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.
    Gu Y; Chen ZW; Siegel A; Koshy R; Ramirez C; Raabe TD; Devries GH; Ilyas AA
    J Neuroimmunol; 2012 May; 246(1-2):58-64. PubMed ID: 22464399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.
    Paparounas K; O'Hanlon GM; O'Leary CP; Rowan EG; Willison HJ
    Brain; 1999 May; 122 ( Pt 5)():807-16. PubMed ID: 10355667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three different anti-myelin antibodies in a case of demyelinating dysglobulinemic peripheral neuropathy.
    Ellie E; Younes-Chennoufi AB; Couto A; Vital A; Hilmi S; Demotes-Mainard J; Baumann N; Petry KG
    J Peripher Nerv Syst; 1997; 2(1):43-8. PubMed ID: 10975735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiserum-mediated demyelination: relationship between remyelination and functional recovery.
    Saida K; Sumner AJ; Saida T; Brown MJ; Silberberg DH
    Ann Neurol; 1980 Jul; 8(1):12-24. PubMed ID: 7406444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies.
    Rosenbluth J; Moon D
    J Neurosci Res; 2003 Jan; 71(1):104-9. PubMed ID: 12478618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-mediated anti-HIV-1 effect induced by human IgM monoclonal antibody against ganglioside GM2.
    Wu X; Okada N; Momota H; Irie RF; Okada H
    J Immunol; 1999 Jan; 162(1):533-9. PubMed ID: 9886430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired infantile abducens palsy associated with anti-GM2 antibodies.
    Smyth KA; Fritzler MJ; Kirton A
    Pediatr Neurol; 2011 Jun; 44(6):459-62. PubMed ID: 21555058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients.
    Yan WX; Taylor J; Andrias-Kauba S; Pollard JD
    Ann Neurol; 2000 Jun; 47(6):765-75. PubMed ID: 10852542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute inflammatory demyelination in reperfusion nerve injury.
    Nukada H; McMorran PD; Shimizu J
    Ann Neurol; 2000 Jan; 47(1):71-9. PubMed ID: 10632103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.
    Ortiz N; Rosa R; Gallardo E; Illa I; Tomas J; Aubry J; Sabater M; Santafé M
    J Neuroimmunol; 2001 Sep; 119(1):114-23. PubMed ID: 11525808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
    Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
    J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block.
    Stubbs EB; Lawlor MW; Richards MP; Siddiqui K; Fisher MA; Bhoopalam N; Siegel GJ
    Acta Neuropathol; 2003 Feb; 105(2):109-16. PubMed ID: 12536221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies.
    Cavanna B; Jiang H; Allaria S; Carpo M; Scarlato G; Nobile-Orazio E
    J Neuroimmunol; 2001 Mar; 114(1-2):226-31. PubMed ID: 11240036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoneurial injection of antisera to myelin antigens.
    Hughes RA; Powell HC; Braheny SL; Brostoff S
    Muscle Nerve; 1985; 8(6):516-22. PubMed ID: 16758576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-induced demyelination: an electrophysiological and histological study.
    Pollard JD; Harrison B; Gatenby P
    Clin Exp Neurol; 1981; 18():70-80. PubMed ID: 6926394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve damage in leprosy-a teased fibre study of sciatic nerves in experimental mice.
    Bhat R; Vaidya MC
    Lepr India; 1982 Jan; 54(1):33-9. PubMed ID: 7098441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-GM2 gangliosides IgM paraprotein induces neuromuscular block without neuromuscular damage.
    Santafé MM; Sabaté MM; Garcia N; Ortiz N; Lanuza MA; Tomàs J
    J Neuroimmunol; 2008 Nov; 204(1-2):20-8. PubMed ID: 18817985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.